Mol Metab 30:72130 Friedrichsen M, Breitschaft A, Tadayon S, Wizert A, Skovgaard D (2021) The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity
Exact p values are indicated
In the GLP-1 space, there are specific products FDA-approved for diabetes and specific products approved for weight loss
These data confirm a pioneering smaller study conducted in Wuhan, China [88] , which reported that elevated GGT levels were common among patients with severe COVID-19 and positively associated with a prolonged hospital stay and severity of disease
The soft tissue component appears slightly hyperdense, which is attributed to melanin